BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
BridgeBio Pharma (Nasdaq: BBIO), a commercial-stage biopharmaceutical company, will participate in the 45th Annual Goldman Sachs Global Healthcare Conference. Founder and CEO Neil Kumar, Ph.D., is scheduled to present on June 12 at 3:20 pm EDT in Miami, FL. The presentation will be available via live webcast on the Investor section of BridgeBio's website, with a replay accessible for 90 days thereafter.
- Participation in a major healthcare conference enhances visibility.
- Live webcast and replay availability could attract potential investors.
- No new products or financial data announced in the press release.
- No detailed information on current financial performance.
PALO ALTO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that Neil Kumar, Ph.D., founder and CEO of BridgeBio, will present at the Goldman Sachs Annual Global Healthcare Conference in Miami, FL on Wednesday, June 12 at 3:20 pm EDT.
To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers, and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter.
BridgeBio Contact:
Vikram Bali
contact@bridgebio.com
(650)-789-8220
FAQ
When will BridgeBio present at the Goldman Sachs Healthcare Conference?
How can I access the live webcast of BridgeBio's presentation?
Will there be a replay of BridgeBio's presentation at the conference?
What is the stock symbol for BridgeBio Pharma?
